Last reviewed · How we verify

Progesterone-IBSA Injectable Solution — Competitive Intelligence Brief

Progesterone-IBSA Injectable Solution (Progesterone-IBSA Injectable Solution) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Progestin. Area: Obstetrics/Gynecology.

phase 3 Progestin Progesterone receptor (PR) Obstetrics/Gynecology Small molecule Live · refreshed every 30 min

Target snapshot

Progesterone-IBSA Injectable Solution (Progesterone-IBSA Injectable Solution) — IBSA Institut Biochimique SA. Progesterone binds to progesterone receptors in the uterus and other reproductive tissues to maintain pregnancy and regulate the menstrual cycle.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Progesterone-IBSA Injectable Solution TARGET Progesterone-IBSA Injectable Solution IBSA Institut Biochimique SA phase 3 Progestin Progesterone receptor (PR)
Slynd DROSPIRENONE Exeltis Usa Inc marketed Progestin Mineralocorticoid receptor 2019-01-01
Natazia DIENOGEST Mochida Pharmaceutical Co., Ltd. marketed Progestin Progesterone receptor 2010-01-01
Mifeprex MIFEPRISTONE Corcept Therap marketed Progestin Antagonist [EPC] Glucocorticoid receptor 2000-01-01
Ortho-Cept DESOGESTREL Merck & Co. marketed Progestin Sex hormone-binding globulin 1992-01-01
Delalutin HYDROXYPROGESTERONE CAPROATE Bristol-Myers Squibb marketed Progestin Corticosteroid-binding globulin 1975-01-01
Megace MEGESTROL ACETATE Bristol-Myers Squibb marketed Progestin Glucocorticoid receptor 1971-01-01

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

Sponsor landscape (Progestin class)

  1. · 2 drugs in this class
  2. Trieu, Nguyen Thi, M.D. · 2 drugs in this class
  3. Bristol-Myers Squibb · 2 drugs in this class
  4. Baylor Research Institute · 1 drug in this class
  5. Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) · 1 drug in this class
  6. Exeltis Usa Inc · 1 drug in this class
  7. IBSA Institut Biochimique SA · 1 drug in this class
  8. Hillel Yaffe Medical Center · 1 drug in this class
  9. Fdn Consumer · 1 drug in this class
  10. Bio Meds Pharmaceutica Ltda · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Progesterone-IBSA Injectable Solution — Competitive Intelligence Brief. https://druglandscape.com/ci/progesterone-ibsa-injectable-solution. Accessed 2026-05-14.

Build your own brief

Pick any drug + add comparators: